Cargando…

Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma

PURPOSE: To investigate the safety of high dose hypofractionated radiotherapy (RT) in patients with small hepatocellular carcinoma (HCC) in terms of liver volumetric changes and clinical liver function. MATERIALS AND METHODS: We retrospectively reviewed 16 patients with small HCC who were treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Young Il, Park, Hee Chul, Lim, Do Hoon, Park, Hyo Jung, Kang, Sang Won, Park, Su Yeon, Kim, Jin Sung, Han, Youngyih, Paik, Seung Woon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Radiation Oncology 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546287/ https://www.ncbi.nlm.nih.gov/pubmed/23346538 http://dx.doi.org/10.3857/roj.2012.30.4.189

Ejemplares similares

Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?
por: Yu, Jeong Il, et al.
Publicado: (2016)

Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2014)

Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
por: Hasan, Shaakir, et al.
Publicado: (2017)

Child-Pugh Score Is an Independent Risk Factor for Immediate Bleeding after Colonoscopic Polypectomy in Liver Cirrhosis
por: Lee, Sangheun, et al.
Publicado: (2014)

Can the model for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A?
por: Kim, Jong Man, et al.
Publicado: (2014)

Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2018)

Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B in Korea (KROG 16-05)
por: Bae, Sun Hyun, et al.
Publicado: (2019)

The Safety and Clinical Outcomes of Chemoembolization in Child-Pugh Class C Patients with Hepatocellular Carcinomas
por: Choi, Tae Won, et al.
Publicado: (2015)

Clinical impact of carbon‐ion radiotherapy on hepatocellular carcinoma with Child‐Pugh B cirrhosis
por: Hiroshima, Yuichi, et al.
Publicado: (2023)

Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
por: Park, Jongmoo, et al.
Publicado: (2018)

Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
por: Miyata, Tatsunori, et al.
Publicado: (2021)

Hypofractionated Radiotherapy for Early-Stage Breast Cancer: A Propensity Score Matched Analysis
por: Lee, Anbok, et al.
Publicado: (2022)

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma
por: Cheon, Jaekyung, et al.
Publicado: (2023)

Electrocardiographic characteristics of cirrhotic patients and their association with Child‐Pugh score
por: Jahangiri, Soodeh, et al.
Publicado: (2023)

Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function
por: Huynh, Jasmine, et al.
Publicado: (2022)

Perioperative and prognostic implication of albumin‐bilirubin‐TNM score in Child‐Pugh class A hepatocellular carcinoma
por: Sonohara, Fuminori, et al.
Publicado: (2018)

Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis
por: Daniell, Kayla M., et al.
Publicado: (2022)

Hypofractionated radiotherapy versus conventional radiotherapy for diffuse intrinsic pontine glioma: A systematic review and meta-analysis
por: Park, Jaehyeon, et al.
Publicado: (2020)

A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images
por: Jung, Sang Hoon, et al.
Publicado: (2016)

Evaluation of Pretreatment Albumin–Bilirubin Grade as a Better Prognostic Factor Compared to Child–Pugh Classification in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization Combined with Radiotherapy
por: Lee, Jason Joon Bock, et al.
Publicado: (2023)

Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma
por: Itoh, Shinji, et al.
Publicado: (2022)

A Comparison of Clinical Manifestations and Prognoses Between Patients with Hepatocellular Carcinoma and Child–Pugh Scores of 5 or 6
por: Hung, Hung-Hsu, et al.
Publicado: (2014)

The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma
por: Ruzzenente, Andrea, et al.
Publicado: (2019)

Correction to: Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis
por: Daniell, Kayla M., et al.
Publicado: (2022)

Effectiveness and Safety of Nivolumab in Child–Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study
por: Choi, Won-Mook, et al.
Publicado: (2020)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy
por: Oh, Dongryul, et al.
Publicado: (2015)

Child-Pugh B or C Cirrhosis Increases the Risk for Bleeding Following Colonoscopic Polypectomy
por: Soh, Hosim, et al.
Publicado: (2020)

Is Laparoscopy-assisted Radical Gastrectomy Safe in Patients with Child-Pugh Class A Cirrhosis?
por: Kang, Sin Jae, et al.
Publicado: (2013)

Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
por: Jiang, Jian-Qiang, et al.
Publicado: (2023)

Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis
por: Dong, Zhao-Ru, et al.
Publicado: (2017)

Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in Child-Pugh class A patients
por: Lee, In Joon, et al.
Publicado: (2019)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients With Child-Pugh B or C Cirrhosis
por: Lee, Peter, et al.
Publicado: (2020)

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
por: Liu, Chen-Hua, et al.
Publicado: (2021)

Differential Impact of Serum 25-Hydroxyvitamin D3 Levels on the Prognosis of Patients with Liver Cirrhosis According to MELD and Child-Pugh Scores
por: Kim, Tae Hyung, et al.
Publicado: (2020)

Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea
por: Park, Sunmin, et al.
Publicado: (2021)

Changes in Inflammatory Markers Predict the Prognosis of Resected Hepatocellular Carcinoma with Child–Pugh A
por: Zhou, Jing, et al.
Publicado: (2022)

Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
por: Costa, Frederico, et al.
Publicado: (2023)

Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture
por: Yoo, Gyu Sang, et al.
Publicado: (2017)

Association of Thyroid Function and Severity of Illness in Liver Cirrhosis as Measured by Child-Pugh Score
por: Raj, Aswin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tjp1r65ouulml30ad63m707clp